Nautilus Biotechnology (NAUT) Treasury Shares (2020)
Nautilus Biotechnology's (NAUT) quarterly Treasury Shares came in at $569721.0 in Q4 2020.
Nautilus Biotechnology (NAUT) Treasury Shares (2020) Analysis & Trends
Nautilus Biotechnology has disclosed Treasury Shares across 1 years of filings, most recently posting $569721.0 for Q4 2020.
- Treasury Shares for Q4 2020 came in at $569721.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $569721.0 (changed N/A YoY), and the FY2020 annual result was $569721.0, changed N/A from the prior year.
- Treasury Shares came in at $569721.0 for Q4 2020 at Nautilus Biotechnology.
- In the past five years, Treasury Shares ranged from a high of $569721.0 in Q4 2020 to a low of $569721.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Nautilus Biotechnology | 289.99 Mn | 194.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 569,721.00 |
| Dec 31, 2020 | 569,721.00 |